BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 24, 2012
View Archived Issues
Bionomics patents novel acetylcholine receptor modulators
Read More
Centaurus BioPharma divulges novel GPR119 receptor agonist
Read More
Dual-action AT1 receptor antagonist/PPAR-gamma agonist selected as clinical candidate
Read More
Pacific Therapeutics advances first-in-human trial of repurposed combination
Read More
Transgenomic receives NIH grant for cancer diagnostic
Read More
Scientists in Germany identify new resistance loci for severe malaria
Read More
Enrollment and dosing begin in first-in-human AT-001 trial
Read More
Bayer kicks off phase III program for ciprofloxacin DPI
Read More
Amgen products target free fatty acid FFA1 receptor for diabetes
Read More
New BACE inhibitor reduces CNS beta-amyloid in vivo
Read More
NIH-sponsored study to evaluate low-dose methotrexate's potential to reduce cardiovascular events
Read More
New PDE2A/10A inhibitors reported
Read More
Investigators extract new HMG-CoA reductase inhibitors from yeast
Read More
Sato Pharmaceutical designs new urate anion exchanger inhibitors
Read More
New antifungals designed in Japan
Read More
Research at U.S. university yields new MAT 2 inhibitors
Read More
New SPT inhibitor selected for further development in hepatitis C
Read More
Janssen launches phase III rheumatoid arthritis program
Read More
PCI Biotech selects next indication for Amphinex
Read More
MediciNova reports encouraging preliminary phase Ib results on bedoradrine
Read More
Once-daily tablets approved in Japan for use in ulcerative colitis in remission
Read More
Growject approved for fourth indication in Japan
Read More
AcelRx kicks off new trial of Sufentanil NanoTabs
Read More
Recordati completes acquisition
Read More
Microbix and Zydus Cadila sign agreement for Kinlytic
Read More
Synergy Pharmaceuticals to acquire nucleoside analogue from Bristol-Myers Squibb
Read More
First angiotensin AT1 receptor antagonist approved for pediatric use in Japan
Read More
Northwest Bio gains MHRA clearance for DCVax-L trial
Read More